Accelerator closes fourth fund at $62.8M

Biotech incubator Accelerator Corp. (Seattle, Wash.) raised $11.7 million, topping off its Accelerator IV fund at $62.8 million. New investors AbbVie Inc. (NYSE:ABBV); WuXi PharmaTech Inc. (NYSE:WX); and Watson Fund participated in the financing. The company plans to invest the fund in early stage life sciences companies, primarily in New York and Seattle (see BioCentury, Aug. 4, 2014). ...